MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

9 hedge funds and large institutions have $1.53M invested in Stealth BioTherapeutics Corp. ADS in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
PM
1
Prosight Management
Texas
$533K -$82.4K -45,023 -13%
Renaissance Technologies
2
Renaissance Technologies
New York
$468K +$234K +127,757 +100%
BBHC
3
Brown Brothers Harriman & Co
New York
$320K
IC
4
Ikarian Capital
Texas
$69K
Millennium Management
5
Millennium Management
New York
$40K -$25.6K -14,056 -39%
PC
6
PA Capital
Virginia
$39K -$1.96K -1,073 -5%
UBS Group
7
UBS Group
Switzerland
$27K +$26.3K +14,600 +3,650%
HF
8
HRT Financial
New York
$25K +$25K +13,751 New
Morgan Stanley
9
Morgan Stanley
New York
$11K
Two Sigma Investments
10
Two Sigma Investments
New York
-$15K -12,434 Closed
Deutsche Bank
11
Deutsche Bank
Germany
-$12K -9,800 Closed